These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2197459)

  • 1. 5-Nitro-ortho-toluidine.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():169-77. PubMed ID: 2197459
    [No Abstract]   [Full Text] [Related]  

  • 2. para-Chloro-ortho-toluidine and its strong acid salts.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():123-37. PubMed ID: 2152766
    [No Abstract]   [Full Text] [Related]  

  • 3. p-Chloro-o-toluidine and p-chloro-o-toluidine hydrochloride.
    Rep Carcinog; 2004; 11():III60-2. PubMed ID: 21089832
    [No Abstract]   [Full Text] [Related]  

  • 4. o-Toluidine and o-toluidine hydrochloride.
    Rep Carcinog; 2004; 11():III258-9. PubMed ID: 21089974
    [No Abstract]   [Full Text] [Related]  

  • 5. Ortho-toluidine (hydrochloride).
    IARC Monogr Eval Carcinog Risk Chem Man; 1978 Jan; 16():349-66. PubMed ID: 640682
    [No Abstract]   [Full Text] [Related]  

  • 6. C.I. Basic Red 9 monohydrochloride.
    Rep Carcinog; 2004; 11():III66-7. PubMed ID: 21089835
    [No Abstract]   [Full Text] [Related]  

  • 7. 4-Chloro-ortho-toluidine.
    IARC Monogr Eval Carcinog Risks Hum; 2000; 77():323-39. PubMed ID: 11100405
    [No Abstract]   [Full Text] [Related]  

  • 8. ortho-Toluidine and ortho-toluidine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():155-75. PubMed ID: 6955262
    [No Abstract]   [Full Text] [Related]  

  • 9. Vat Yellow 4.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():161-8. PubMed ID: 2197458
    [No Abstract]   [Full Text] [Related]  

  • 10. [The carcinogenic effect of chlordimeform and 4-chloro-o-toluidine].
    Popp W; Norpoth K
    Dtsch Med Wochenschr; 1991 Sep; 116(38):1454. PubMed ID: 1893862
    [No Abstract]   [Full Text] [Related]  

  • 11. [4-Chloro-o-toluidine-induced bladder cancer].
    Stasik MJ
    Dtsch Med Wochenschr; 1991 Sep; 116(38):1444-7. PubMed ID: 1893857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental study of ortho-toluidine carcinogenicity].
    Pliss GB
    Vopr Onkol; 2004; 50(5):567-71. PubMed ID: 15715098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Para-chloro-ortho-toluidine (hydrochloride).
    IARC Monogr Eval Carcinog Risk Chem Man; 1978 Jan; 16():277-85. PubMed ID: 640673
    [No Abstract]   [Full Text] [Related]  

  • 14. Disperse Yellow 3.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():149-59. PubMed ID: 2197457
    [No Abstract]   [Full Text] [Related]  

  • 15. 3,3'-Dimethylbenzidine and dyes metabolized to 3,3'-dimethylbenzidine: 3,3'-dimethylbenzidine.
    National Toxicology Program
    Rep Carcinog; 2011; 12():168-70. PubMed ID: 21852829
    [No Abstract]   [Full Text] [Related]  

  • 16. Disperse Blue 1.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():139-48. PubMed ID: 2197456
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyes metabolized to 3,3'-dimethylbenzidine (3,3'-dimethylbenzidine dye class).
    National Toxicology Program
    Rep Carcinog; 2011; 12():170-1. PubMed ID: 21852830
    [No Abstract]   [Full Text] [Related]  

  • 18. The genetic toxicology of ortho-toluidine.
    Danford N
    Mutat Res; 1991 Nov; 258(3):207-36. PubMed ID: 1719402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluating the carcinogenicity of ortho-toluidine: a new conclusion and its implications.
    Sellers C; Markowitz S
    Regul Toxicol Pharmacol; 1992 Dec; 16(3):301-17. PubMed ID: 1293647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrections to: Markowitz SB, Levin K. Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory. J Occup Environ Med. 2004;46:154-160.
    Markowitz SB
    J Occup Environ Med; 2005 Sep; 47(9):875-7. PubMed ID: 16155471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.